test redirect
nand
Products
Solutions
Discover & Learn
Resources & Tools
Support
You are now leaving the BD Biosciences website. The site you are about to visit is operated by a third party. The link to this site neither makes nor implies any representation or warranty for any products or services offered on a third-party site and is intended only to enable convenient access to the third-party site and for no other purpose. Do you want to continue?
Old Browser
For the best web browsing experience, please use Chrome, Safari or Firefox, minimum versions 77.0.3865, 12.1.2 and 68, respectively.
*Required fields
References
- Goetz C, Hammerbeck C, Bonnevier J. Flow Cytometry Basics for the Non-Expert. Springer International Publishing; 2018. doi:10.1007/978-3-319-98071-3
- Shapiro HM. Practical Flow Cytometry. 4th ed. John Wiley & Sons; 2003.
- Ruiz F, Wyss A, Rossel JB, et al. A single nucleotide polymorphism in the gene for GPR183 increases its surface expression on blood lymphocytes of patients with inflammatory bowel disease. Br J Pharmacol. 2021;178(16):3157-3175. doi:10.1111/bph.15395
- Frerou A, Lesouhaitier M, Gregoire M, et al. Venoarterial extracorporeal membrane oxygenation induces early immune alterations. Crit Care. 2021;25(1):9. doi:10.1186/s13054-020-03444-x
- SMOLEJ L, VROBLOVA V, MOTYCKOVA M, et al. Quantification of ZAP-70 expression in chronic lymphocytic leukemia: T/B-cell ratio of mean fluorescence intensity provides stronger prognostic value than percentage of positive cells. Neoplasma. 2011;58(2):140-145. doi:10.4149/neo_2011_02_140
- Wu YJ, Wang H, Liang JH, et al. Using the geometric mean fluorescence intensity index method to measure ZAP-70 expression in patients with chronic lymphocytic leukemia. Onco Targets Ther. Published online February 2016:797. doi:10.2147/OTT.S94613
© 2023 BD. All rights reserved. Unless otherwise noted, BD, the BD Logo and all other trademarks are the property of Becton, Dickinson and Company or its affiliates.
Report a Site Issue
This form is intended to help us improve our website experience. For other support, please visit our Contact Us page.
Successfully submitted.